Rothschild Investment Corp IL lifted its holdings in Metlife Inc (NYSE:MET) by 2.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 81,678 shares of the financial services provider’s stock after acquiring an additional 2,317 shares during the period. Rothschild Investment Corp IL’s holdings in Metlife were worth $3,816,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also bought and sold shares of the company. FMR LLC raised its position in shares of Metlife by 9.2% in the 2nd quarter. FMR LLC now owns 46,737,949 shares of the financial services provider’s stock worth $2,037,775,000 after acquiring an additional 3,921,155 shares in the last quarter. Pzena Investment Management LLC raised its position in shares of Metlife by 39.3% in the 2nd quarter. Pzena Investment Management LLC now owns 8,314,788 shares of the financial services provider’s stock worth $362,525,000 after acquiring an additional 2,346,866 shares in the last quarter. Morgan Stanley raised its position in shares of Metlife by 12.3% in the 2nd quarter. Morgan Stanley now owns 6,357,267 shares of the financial services provider’s stock worth $277,177,000 after acquiring an additional 696,768 shares in the last quarter. LSV Asset Management raised its position in shares of Metlife by 7.4% in the 2nd quarter. LSV Asset Management now owns 4,098,468 shares of the financial services provider’s stock worth $178,693,000 after acquiring an additional 283,900 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. raised its position in shares of Metlife by 0.8% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,844,484 shares of the financial services provider’s stock worth $167,620,000 after acquiring an additional 29,491 shares in the last quarter. 77.47% of the stock is owned by hedge funds and other institutional investors.

MET has been the subject of several research analyst reports. Zacks Investment Research lowered Metlife from a “buy” rating to a “hold” rating in a research report on Tuesday, July 3rd. Barclays lowered their price objective on Metlife from $60.00 to $57.00 and set an “overweight” rating for the company in a research report on Monday, July 9th. Morgan Stanley lowered their price objective on Metlife from $53.00 to $52.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 11th. B. Riley lowered their price objective on Metlife from $58.00 to $50.00 and set a “neutral” rating for the company in a research report on Monday, July 16th. Finally, Sandler O’Neill reissued a “hold” rating and issued a $50.00 price objective on shares of Metlife in a research report on Thursday, August 2nd. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $55.00.

Metlife stock traded up $0.81 during midday trading on Wednesday, reaching $44.66. The stock had a trading volume of 570,089 shares, compared to its average volume of 5,973,705. Metlife Inc has a 12 month low of $42.80 and a 12 month high of $55.91. The firm has a market capitalization of $46.48 billion, a price-to-earnings ratio of 9.94, a PEG ratio of 0.71 and a beta of 1.23. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.15 and a quick ratio of 0.15.

Metlife (NYSE:MET) last issued its earnings results on Wednesday, August 1st. The financial services provider reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.13. The business had revenue of $21.22 billion during the quarter, compared to analyst estimates of $15.65 billion. Metlife had a return on equity of 9.17% and a net margin of 6.12%. The firm’s revenue was up 36.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.04 EPS. On average, sell-side analysts expect that Metlife Inc will post 5.22 EPS for the current year.

In other Metlife news, Chairman Steven A. Kandarian sold 85,683 shares of Metlife stock in a transaction dated Tuesday, August 21st. The stock was sold at an average price of $46.93, for a total transaction of $4,021,103.19. Following the completion of the transaction, the chairman now owns 585,005 shares in the company, valued at approximately $27,454,284.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Steven A. Kandarian sold 42,805 shares of Metlife stock in a transaction dated Monday, August 27th. The shares were sold at an average price of $47.03, for a total value of $2,013,119.15. Following the transaction, the chairman now owns 559,097 shares of the company’s stock, valued at approximately $26,294,331.91. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by insiders.

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Read More: How Do You Calculate Return on Investment (ROI)?

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.